HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nam Hoon Kim Selected Research

Metformin (Glucophage)

9/2023Glucometabolic control of once-weekly dulaglutide switched from DPP4 inhibitor versus daily empagliflozin add-on in patients with type 2 diabetes inadequately controlled with metformin, sulfonylurea, and DPP4 inhibitor: A randomised trial.
12/2021Fasting Glucose Variability as a Risk Indicator for End-Stage Kidney Disease in Patients with Diabetes: A Nationwide Population-Based Study.
11/2019Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort study.
1/2018Efficacy and tolerability of novel triple combination therapy in drug-naïve patients with type 2 diabetes from the TRIPLE-AXEL trial: protocol for an open-label randomised controlled trial.
6/2017Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nam Hoon Kim Research Topics

Disease

28Type 2 Diabetes Mellitus (MODY)
01/2024 - 05/2017
14Cardiovascular Diseases (Cardiovascular Disease)
03/2024 - 01/2018
7Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2023 - 07/2013
6Ischemic Stroke
11/2023 - 01/2018
6Infections
05/2022 - 05/2005
6Non-alcoholic Fatty Liver Disease
07/2021 - 04/2014
5Neoplasms (Cancer)
03/2024 - 09/2005
5Dyslipidemias (Dyslipidemia)
11/2023 - 12/2021
5Chronic Kidney Failure (Chronic Renal Failure)
12/2021 - 01/2019
5Diabetes Mellitus
07/2021 - 01/2017
4Diabetes Complications
11/2023 - 12/2018
4Insulin Resistance
01/2023 - 09/2018
4Myocardial Infarction
09/2022 - 01/2018
4COVID-19
05/2022 - 01/2021
4Inflammation (Inflammations)
01/2020 - 05/2005
4Stroke (Strokes)
01/2020 - 11/2017
3Heart Failure
11/2023 - 11/2019
3Myocardial Ischemia (Ischemic Heart Diseases)
11/2023 - 11/2019
3Body Weight (Weight, Body)
09/2023 - 09/2018
3Thyroid Neoplasms (Thyroid Cancer)
01/2023 - 10/2016
3Atherosclerosis
01/2023 - 07/2013
3Dementia (Dementias)
11/2022 - 11/2017
3Albuminuria
01/2021 - 01/2019
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2007 - 09/2003
2Hyperglycemia
11/2023 - 01/2022
2Glucose Intolerance
01/2023 - 09/2018
2Necrosis
08/2022 - 12/2009
2Hypertension (High Blood Pressure)
12/2021 - 01/2021
2Hypothyroidism
05/2019 - 10/2016
2Atrial Fibrillation
01/2019 - 11/2004
2Renal Insufficiency (Renal Failure)
01/2018 - 12/2006
2Hepatocellular Carcinoma (Hepatoma)
10/2014 - 05/2005
2Chronic Hepatitis B
09/2009 - 06/2004
1Graves Disease (Basedow Disease)
03/2024
1Heart Diseases (Heart Disease)
11/2023
1Weight Gain
11/2023
1Hyperphagia (Overeating)
11/2023
1Weight Loss (Weight Reduction)
09/2023
1Cachexia
01/2023
1Anorexia
01/2023
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2023

Drug/Important Bio-Agent (IBA)

18Glucose (Dextrose)FDA LinkGeneric
11/2023 - 12/2009
6Sodium-Glucose Transport ProteinsIBA
03/2024 - 01/2018
6Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2023 - 01/2019
6Triglycerides (Triacylglycerol)IBA
01/2023 - 04/2014
5Metformin (Glucophage)FDA LinkGeneric
09/2023 - 06/2017
5Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2023 - 05/2017
5Indicators and Reagents (Reagents)IBA
12/2021 - 11/2017
4Sodium-Glucose Transporter 2 InhibitorsIBA
03/2024 - 10/2019
4Insulin (Novolin)FDA Link
11/2023 - 05/2017
4LipidsIBA
11/2023 - 01/2019
4Dipeptidyl-Peptidase IV InhibitorsIBA
09/2023 - 06/2017
4Proteins (Proteins, Gene)FDA Link
08/2022 - 01/2007
4Biomarkers (Surrogate Marker)IBA
11/2021 - 07/2013
4CholesterolIBA
01/2021 - 01/2019
4Hypoglycemic Agents (Hypoglycemics)IBA
10/2019 - 05/2017
3Fenofibrate (CiL)FDA LinkGeneric
11/2023 - 01/2019
3omega-Chloroacetophenone (Mace)IBA
11/2023 - 01/2022
3Vitamin DFDA LinkGeneric
01/2023 - 11/2015
3CalciumIBA
01/2023 - 12/2009
3IodineIBA
01/2023 - 10/2020
3EnzymesIBA
01/2023 - 01/2018
3LDL CholesterolIBA
01/2023 - 01/2022
3C-Reactive ProteinIBA
10/2018 - 06/2017
2Lipoproteins (Lipoprotein)IBA
11/2023 - 01/2023
2empagliflozinIBA
09/2023 - 01/2023
2ImmunosorbentsIBA
01/2023 - 02/2018
2oxidized low density lipoproteinIBA
01/2023 - 01/2022
2VaccinesIBA
07/2022 - 01/2021
2Immunoglobulin G (IgG)IBA
05/2022 - 05/2005
2SodiumIBA
01/2022 - 12/2009
2Antiviral Agents (Antivirals)IBA
01/2021 - 09/2009
2TransferasesIBA
01/2020 - 01/2020
2Thyroxine (Levothyroxine)FDA LinkGeneric
05/2019 - 10/2016
2SteroidsIBA
05/2019 - 11/2007
2CreatinineIBA
10/2018 - 12/2006
2Alanine Transaminase (SGPT)IBA
10/2018 - 01/2018
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
09/2005 - 05/2005
2CopperIBA
08/2004 - 09/2003
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2024
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
11/2023
1Rosuvastatin Calcium (Crestor)FDA Link
11/2023
1LeptinIBA
11/2023
1O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA
11/2023
1NeuropeptidesIBA
11/2023
1MelanocortinsIBA
11/2023
1Ezetimibe (Zetia)FDA Link
11/2023
1dulaglutideIBA
09/2023
1Fibroblast Growth Factor 1 (FGF-1)IBA
01/2023

Therapy/Procedure

18Therapeutics
03/2024 - 11/2004
4Glycemic Control
11/2023 - 08/2017
3Renal Replacement Therapy (Therapies, Renal Replacement)
01/2022 - 11/2019
2Gastrectomy
01/2022 - 05/2006
2Aftercare (After-Treatment)
06/2017 - 11/2007
2Enema (Enemas)
12/2009 - 02/2006
1Caloric Restriction
11/2023
1Light Coagulation
01/2023
1Lasers (Laser)
01/2023
1Vitrectomy
01/2023
1Drug Therapy (Chemotherapy)
01/2023